These data highlight the importance of preventing the loss of 24-OHC in the AD brain, which was demonstrated in our previous study [34], in order to preserve the activity of this pathway and, consequently, to limit tau accumulation during the progression of AD. This evidence concerns the gene MAPT and Alzheimer disease.